Abstract:Objective To explore the clinicopathological features,diagnosis,differential diagnosis and treatment of congenital hemangioma (CH).Methods The clinical data,pathological characteristics and treatment of 32 CH cases were analyzed retrospectively.Results There were 20 boys and 12 girls with a boy-to-girl ratio of 1.6∶1 and a median age of 43 months.All were unifocal lesions at head & neck region (n =8),trunk (n =12),upper extremities (n =5) and lower extremities (n =7).One lesion was detected by prenatal ultrasonography and the remainder was present at birth.Twenty-five lesions gradually expanded in size,3 lesions had slight regression and 4 cases showed no obvious changes.One lesion felt warm on palpation,one with sinus at the center of mass while the remainder had no local pain,swelling or ulceration.All lesions had normal preoperative results of blood routine and blood coagulation function.One child received a preoperative injection of sclerosant.However,mass had no regression.All cases underwent complete resection.One child of excessive intraoperative hemorrhage received blood transfusion postoperatively.The clinical types were rapidly involuting congenital hemangioma (RICH,n =3) and noninvoluting congenital hemangioma (NICH,n =29).NICH:Tumor was dominated by lobules of capillaries,separated by dense fibrous tissues containing lymphatic vessels and small arteriovenous structures.Small intralobular vessels were lined by endothelial cells with hobnailed nuclei.The center of lobule was occupied by stelliform vessels.RICH:Tumor was dominated by lobules of capillaries,similar to those seen in NICH,most intralobular vessels were atretic and the remainder diminished.Endothelial cells became flattened.Focal hemorrhagic necrosis,hemosiderosis and calcification were observed.Immunohistochemistry showed that all cases were negative for Glut1,positive for CD34(32/32),CD31 (32/32) and WT1 (32/32) and D2-40 was partially positive.Twenty-five cases were followed up for 3-25 months.Slight linear scar was present.Recurrence was not found.Conclusions CH is a benign vascular tumor whose diagnosis (RICH or NICH) depends upon clinical manifestations and pathological morphology.Clinically and pathologically,it needs to be differentiated from vascular malformation,infantile hemangiomas,kaposiform hemangioendothelioma and pyogenic granuloma.

Location of infantile hemangioma is a predictor of volumetric sequelae after involution.

A 7-Year Follow-Up Study on Untreated Deep or Mixed Facial Infantile Hemangioma in East-Asian Patients: when Propranolol Was Not Yet an Option

Retrospective Study of Nasal Infantile Hemangiomas: Characteristics, Complications, and Outcomes

Liposuction for Large Facial Involuted Infantile Hemangiomas in Children: Clinical Evaluation and Management Strategies

Parental Assessment of Infantile Hemangioma Cosmetic Clinical Outcomes: Results of the Spanish Hemangioma Nationwide Prospective Cohort

Clinical and Radiological Outcomes of Infantile Hemangioma Treated with Oral Propranolol: A Long‐term Follow‐up Study

Management of congenital hemangioma: clinicopathological analysis of 32 cases

Historical and contemporary management of infantile hemangiomas: a single-center experience

Infantile hemangioma precursor lesions on day of life 1: A Mayo Clinic retrospective case series

Does Oral Propranolol Improve the Final Outcome of All Involuted Infantile Hemangiomas? A Matched Retrospective Comparative Study

Periocular Infantile Hemangiomas: Characteristics, Ocular Sequelae, and Outcomes

Progress In The Treatment Of Infantile Hemangioma

Insights into the mechanisms of angiogenesis in infantile hemangioma

Research Progress on Markers of Infantile Hemangioma

The prevalence, complications, and risk factors for infantile hemangioma: a systematic review and meta‐analysis

Infantile Hemangioma: Factors Causing Recurrence after Propranolol Treatment

A PRELIMINARY STUDY ON CLINICAL FEATURE OF INFANTILE HEMANGIOMA AND VASCULAR MALFORMATION

Algorithm-based Management of Infantile Hemangiomas: Reducing Sequelae and Surgical Interventions

A prospective self-controlled phase II study of imiquimod 5% cream in the treatment of infantile hemangioma.

Signaling pathways in the development of infantile hemangioma

Maternal and Perinatal Risk Factors for Infantile Hemangioma: a Case-Control Study.